ESC 365 - Should beta-blockers be stopped in HFrEF and atrial fibrillation?

ESC Premium Access

Should beta-blockers be stopped in HFrEF and atrial fibrillation?

Session: The future therapy of heart failure: shall we find the answers in the crystal ball?

Topic: AHF - Drug treatment

Speaker: Professor T. McDonagh (London, GB)

Event: ESC Congress 2017

Congress Presentation

Add to my library

About the speaker

Professor Theresa McDonagh

King's College Hospital, London (United Kingdom of Great Britain & Northern Ireland)

60 presentations

35 followers

3 more presentations in this session

Will ACE inhibitors be abandoned in the treatment of HFrEF?

Speaker: Professor J. McMurray (Glasgow, GB)

Will we use VADs to recover the failing heart in the future?

Speaker: Doctor S. Drakos (Salt Lake City, US)

The path to leadless CRT.

Speaker: Professor J. Cleland (Glasgow, GB)

Access the full session

The future therapy of heart failure: shall we find the answers in the crystal ball?

Speakers: Professor T. McDonagh, Professor J. McMurray, Doctor S. Drakos, Professor J. Cleland

About the event

ESC Congress 2017

26 August - 30 August 2017

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources